60 Degrees Pharms Drug Patent Portfolio

60 Degrees Pharms owns 1 orange book drug protected by 3 US patents Given below is the list of 60 Degrees Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10342791 Regimens of tafenoquine for prevention of malaria in malaria-naive subjects 02 Dec, 2035
Active
US10888558 Regimens of tafenoquine for prevention of malaria in malaria-naive subjects 02 Dec, 2035
Active
US11744828 Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects 02 Dec, 2035
Active


Given below is the list of recent legal activities going on the following drug patents of 60 Degrees Pharms.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 26 Jun, 2024 US10888558
Email Notification 05 Sep, 2023 US11744828
Mail Patent eGrant Notification 05 Sep, 2023 US11744828
Patent eGrant Notification 05 Sep, 2023 US11744828
Recordation of Patent Grant Mailed 05 Sep, 2023 US11744828
Recordation of Patent eGrant 05 Sep, 2023 US11744828
Patent Issue Date Used in PTA Calculation 05 Sep, 2023 US11744828
Electronic Review 17 Aug, 2023 US11744828
Email Notification 17 Aug, 2023 US11744828
Issue Notification Mailed 16 Aug, 2023 US11744828
Application Is Considered Ready for Issue 26 Jul, 2023 US11744828
Dispatch to FDC 26 Jul, 2023 US11744828
Issue Fee Payment Received 17 Jul, 2023 US11744828
Issue Fee Payment Verified 17 Jul, 2023 US11744828
Miscellaneous Incoming Letter 11 Jul, 2023 US11744828


60 Degrees Pharms's Family Patents

60 Degrees Pharms drugs have patent protection in a total of 7 countries. It's US patent count contributes only to 46.2% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



60 Degrees Pharms Drug List

Given below is the complete list of 60 Degrees Pharms's drugs and the patents protecting them.


1. Arakoda

Arakoda is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10342791 Regimens of tafenoquine for prevention of malaria in malaria-naive subjects 02 Dec, 2035
(11 years from now)
Active
US10888558 Regimens of tafenoquine for prevention of malaria in malaria-naive subjects 02 Dec, 2035
(11 years from now)
Active
US11744828 Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects 02 Dec, 2035
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arakoda's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List